QuarkBio Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series A
- Investors
-
1
QuarkBio General Information
Description
Operator of a biotechnology firm intended to develop faster diagnostic testing methods. The company's platform specializes in precision medicine through its analysis system by delivering biomarker panels to resolve unmet clinical needs as well as focusing on delivering precision cancer and fertility testing solutions, enabling patients to improve their quality of life without the financial burden of long-term healthcare.
Contact Information
Website
www.quarkbiosciences.comCorporate Office
- 6-2 Shengyi Road, Sector 2, 4F-1
- Hsinchu Biomedical Science Park, Hsinchu
- Zhubei
- Taiwan
Corporate Office
- 6-2 Shengyi Road, Sector 2, 4F-1
- Hsinchu Biomedical Science Park, Hsinchu
- Zhubei
- Taiwan
QuarkBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC (Series A) | 15-Dec-2020 | Completed | Generating Revenue |
QuarkBio Patents
QuarkBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3805406-A1 | Digital and quantitative pcr measuring method for nucleic acid sample | Active | 09-Oct-2019 | ||
| EP-3805406-B1 | Digital and quantitative pcr measuring method for nucleic acid sample | Active | 09-Oct-2019 | ||
| JP-2021058171-A | Digital quantitative pcr measurement method for nucleic acid sample | Active | 09-Oct-2019 | ||
| JP-2023139115-A | Endometrial mirna receptivity analysis | Pending | 02-Jul-2019 | ||
| WO-2021000893-A1 | Mirna receptivity analysis of the endometrium | Inactive | 02-Jul-2019 | C12Q1/6883 |
QuarkBio Signals
QuarkBio Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Recharge Capital | Venture Capital | Minority |
QuarkBio Investments (1)
QuarkBio’s most recent deal was a Early Stage VC with PharusDx. The deal was made on 30-May-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PharusDx | 30-May-2024 | Early Stage VC | Biotechnology |
QuarkBio Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Inti Labs | Zhubei City, Taiwan | 2022 |
QuarkBio FAQs
-
When was QuarkBio founded?
QuarkBio was founded in 2012.
-
Where is QuarkBio headquartered?
QuarkBio is headquartered in Zhubei, Taiwan.
-
What is the size of QuarkBio?
QuarkBio has 18 total employees.
-
What industry is QuarkBio in?
QuarkBio’s primary industry is Diagnostic Equipment.
-
Is QuarkBio a private or public company?
QuarkBio is a Private company.
-
What is QuarkBio’s current revenue?
The current revenue for QuarkBio is .
-
Who are QuarkBio’s investors?
Recharge Capital has invested in QuarkBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process